Russell J. Glapion

FDA investigator

Appears on 18 documents from 2013 to 2021, mostly at sites in New Jersey. Most often cites design and construction features (21 CFR 211.42).

18
Documents on file
4.1
Observations per 483
2013
First seen
2021
Most recent

What they cite most

From 73 observations

Activity by year

2013: 3, 2015: 2, 2017: 2, 2018: 2, 2019: 4, 2020: 3, 2021: 2

Where

New Jersey 14 · Germany 1 · Missouri 1 · Switzerland 1 · United Kingdom 1

Is Russell J. Glapion coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

18 documents, newest first
FirmOpen
483 Cetylite Industries, Inc.Sep 24, 2021 · Pennsauken, New Jersey
483 CMIC CMO USA CORPORATIONMay 4, 2021 · Cranbury, New Jersey
483 Stokes Healthcare Inc. dba Epicur PharmaOct 9, 2020 · Mount Laurel, New Jersey
483 Ophtapharm AGFeb 28, 2020 · Hettlingen, Switzerland
483 Pharbil Waltrop GmbHFeb 14, 2020 · Waltrop, Germany
483 Cetylite Industries, Inc.Dec 20, 2019 · Pennsauken, New Jersey
483 Renaissance Lakewood LLCAug 22, 2019 · Lakewood, New Jersey

About this profile

What does Russell J. Glapion inspect?

Russell J. Glapion appears on 18 documents on file covering 16 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.100 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Russell J. Glapion is dated Sep 24, 2021.